Skip to main content
SpringerLink
Log in

Current Status of Catheter-Based Treatment of Mitral Valve Regurgitation

  • Interventional Cardiology (SR Bailey, Section Editor)
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

This review examines the current status of catheter-based repair and replacement for mitral valve disease, with a focus on native primary and secondary mitral valve regurgitation.

Recent Findings

Transcatheter mitral valve repair with the MitraClip®, with >40,000 performed procedures worldwide, has significantly advanced the field of transcatheter therapy for mitral valve regurgitation. Transcatheter mitral valve replacement remains in the early stages of development, mainly due to the complex anatomy and physiology of the mitral valve. Early feasibility studies in high-risk patients show promising procedural success, yet the adverse events require further study.

Summary

Transcatheter therapies for mitral valve disease are the next endeavor for the pioneers of percutaneous structural heart disease interventions. Early results are encouraging but also show that further rigorous study is needed to determine efficacy and safety.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. • Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet. 2009;373(9672):1382–94. This is an excellent general review of mitral valve regurgitation.

    Article  PubMed  Google Scholar 

  2. •• Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005–11. This is still the reference paper for the burden of valvular heart disease in the USA.

    Article  PubMed  Google Scholar 

  3. Rossi A, Zoppini G, Benfari G, Geremia G, Bonapace S, Bonora E, et al. Mitral regurgitation and increased risk of all-cause and cardiovascular mortality in patients with type 2 diabetes. Am J Med. 2016.

  4. Badhwar V, Peterson ED, Jacobs JP, He X, Brennan JM, O'Brien SM, et al. Longitudinal outcome of isolated mitral repair in older patients: results from 14,604 procedures performed from 1991 to 2007. Ann Thorac Surg. 2012;94(6):1870–7. discussion 7-9.

    Article  PubMed  Google Scholar 

  5. • David TE, Armstrong S, McCrindle BW, Manlhiot C. Late outcomes of mitral valve repair for mitral regurgitation due to degenerative disease. Circulation. 2013;127(14):1485–92. This is an important paper highlighting excellent long-term outcomes with surgical mitral valve repair for DMR.

    Article  PubMed  Google Scholar 

  6. • Suri RM, Burkhart HM, Daly RC, Dearani JA, Park SJ, Sundt 3rd TM, et al. Robotic mitral valve repair for all prolapse subsets using techniques identical to open valvuloplasty: establishing the benchmark against which percutaneous interventions should be judged. J Thorac Cardiovasc Surg. 2011;142(5):970–9. This is an important paper higlighting the success of minimally invasive surgical repair in DMR. Any percutaneous approach will have to be judged against this benchmark if low- and intermediate-risk patients should be approached in the future.

    Article  PubMed  Google Scholar 

  7. Goel SS, Bajaj N, Aggarwal B, Gupta S, Poddar KL, Ige M, et al. Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine the potential role of MitraClip for this unmet need. J Am Coll Cardiol. 2014;63(2):185–6.

    Article  PubMed  Google Scholar 

  8. • Taramasso M, Kuwata S, Rodriguez Cetina Biefer H, Nietlispach F, Maisano F. Percutaneous mitral valve repair and replacement: complementary or competitive techniques? EuroIntervention. 2016;12(Y):Y97–Y101. This review article nicely summarizes current mitral valve repair and replacement technologies.

    Article  PubMed  Google Scholar 

  9. •• Sorajja P, Mack M, Vemulapalli S, Holmes Jr DR, Stebbins A, Kar S, et al. Initial experience with commercial transcatheter mitral valve repair in the United States. J Am Coll Cardiol. 2016;67(10):1129–40. This paper is the current reference paper for Mitraclip US TVT registry results and helps you and the patients to make an informed decision.

    Article  PubMed  Google Scholar 

  10. Feldman T, Kar S, Elmariah S, Smart SC, Trento A, Siegel RJ, et al. Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol. 2015;66(25):2844–54.

    Article  PubMed  Google Scholar 

  11. • Ramlawi B, Gammie JS. Mitral valve surgery: current minimally invasive and transcatheter options. Methodist Debakey Cardiovasc J. 2016;12(1):20–6. This review gives a nice overview of not only transcatheter but also minimally invasive surgical advances for mitral valve regurgitation.

    Article  PubMed  PubMed Central  Google Scholar 

  12. • Hoffmann G, Lutter G, Cremer J. Durability of bioprosthetic cardiac valves. Dtsch Arztebl Int. 2008;105(8):143–8. This nicely written review serves a good reference for current durability of bioprostheses.

    PubMed  PubMed Central  Google Scholar 

  13. Vohra HA, Whistance RN, Roubelakis A, Burton A, Barlow CW, Tsang GM, et al. Outcome after redo-mitral valve replacement in adult patients: a 10-year single-centre experience. Interact Cardiovasc Thorac Surg. 2012;14(5):575–9.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Bouleti C, Fassa AA, Himbert D, Brochet E, Ducrocq G, Nejjari M, et al. Transfemoral implantation of transcatheter heart valves after deterioration of mitral bioprosthesis or previous ring annuloplasty. JACC Cardiovasc Interv. 2015;8(1 Pt A):83–91.

    Article  PubMed  Google Scholar 

  15. Lauterbach M, Sontag B, Paraforos A, Friedrich I, Hauptmann KE. Transcatheter valve-in-ring implantation of a repositionable valve system for treatment of severe mitral regurgitation. Catheter Cardiovasc Interv. 2016;88(6):E183–E90.

    Article  PubMed  Google Scholar 

  16. Dvir D, Webb J. Mitral valve-in-valve and valve-in-ring: technical aspects and procedural outcomes. EuroIntervention. 2016;12(Y):Y93–6.

    Article  PubMed  Google Scholar 

  17. • Guerrero M, Dvir D, Himbert D, Urena M, Eleid M, Wang DD, et al. Transcatheter mitral valve replacement in native mitral valve disease with severe mitral annular calcification: results from the first multicenter global registry. JACC Cardiovasc Interv. 2016;9(13):1361–71. This paper is the current reference paper for valve-in-MAC transcatheter therapy. It shows the good procedural success rate but also reminds us that more work is needed due to the high early mortality rate.

    Article  PubMed  Google Scholar 

  18. Sondergaard L, De Backer O, Franzen OW, Holme SJ, Ihlemann N, Vejlstrup NG, et al. First-in-human case of transfemoral CardiAQ mitral valve implantation. Circ Cardiovasc Interv. 2015;8(7):e002135.

    Article  PubMed  Google Scholar 

  19. • Blanke P, Naoum C, Dvir D, Bapat V, Ong K, Muller D, et al. Predicting LVOT obstruction in transcatheter mitral valve implantation: concept of the neo-LVOT. JACC Cardiovasc Imaging. 2016; doi:10.1016/j.jcmg.2016.01.005. This is the first reference paper explaining the concept and CT-based assessment of the “neo-LVOT” after trancatheter mitral valve replacement.

    Google Scholar 

  20. •• Goldstein D, Moskowitz AJ, Gelijns AC, Ailawadi G, Parides MK, Perrault LP, et al. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. 2016;374(4):344–53. This is the reference paper for a comparison of mitral valve repair vs. replacement for severe ischemic (functional) mitral valve regurgitation.

    Article  CAS  PubMed  Google Scholar 

  21. Maisano F, Franzen O, Baldus S, Schafer U, Hausleiter J, Butter C, et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol. 2013;62(12):1052–61.

    Article  PubMed  Google Scholar 

  22. Nickenig G, Estevez-Loureiro R, Franzen O, Tamburino C, Vanderheyden M, Luscher TF, et al. Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 pilot European sentinel registry. J Am Coll Cardiol. 2014;64(9):875–84.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Valve Science Center, Minneapolis Heart Institute Abbott Northwestern Hospital, part of Allina Health, 920 East 28th Street, Suite 300, Minneapolis, MN, 55407, USA

    Mario Gössl, Robert S. Farivar, Richard Bae & Paul Sorajja

Authors
  1. Mario Gössl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert S. Farivar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Richard Bae
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Paul Sorajja
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mario Gössl.

Ethics declarations

Conflict of Interest

Mario Gössl declares that he has no conflict of interest.

Dr. Farivar reports personal fees from Edwards Lifesciences, Medtronic, and Abbott Vascular.

Dr. Bae reports personal fees from Abbott Vascular.

Dr. Sorajja reports personal fees from Abbott Vascular, Boston Scientific, Medtronic, and Lake Regions Medical.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Interventional Cardiology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gössl, M., Farivar, R.S., Bae, R. et al. Current Status of Catheter-Based Treatment of Mitral Valve Regurgitation. Curr Cardiol Rep 19, 38 (2017). https://doi.org/10.1007/s11886-017-0852-z

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11886-017-0852-z

Keywords

Search

Navigation